Tag Archives: biotechnology law

Supreme Court Will Not Review Therasense Standards – Yet

On October 15, 2013, after reviewing the Government’s Amicus Brief (a copy is available at the end of this post), the Supreme Court denied the petition for cert. filed by Sony Computer Entertainment, one of the defendants in 1st Media, … Continue reading

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , , , , , | Leave a comment

Cert. Denied in Intema Ltd. v. PerkinElmer, Inc.

On October 7, 2013, the S. Ct. denied cert., ending Intema’s appeal of the Fed. Cir. decision that its patent claims on a method to determine the level of risk of a Down syndrome pregnancy were not patent-eligible subject matter … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Skinmedica, Inc. and, i.e., Disclaimer

The Fed. Cir. has been pretty hard on defendants alleging disclaimer of claim scope in recent decisions but that was not the case here. But what caught my attention is that Judge Prost spent four pages of his opinion on … Continue reading

Posted in Claim Interpretation | Tagged , , , , , , , , , | 3 Comments

Teresa Stanek Rea Announces Her Departure From the PTO

Acting USPTO Director Teresa “Terry” Rea has announced that she will leave the PTO after a new Director is selected. She will probably complete two years in the position, which has been affected by the sequestration of funding, a backlog … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment